CRIM1 Antibodies

Santa Cruz Biotechnology offers a broad range of CRIM1 monoclonal antibodies for research focused on understanding CRIM1 protein functions. CRIM1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CRIM1, or cysteine-rich motor neuron 1, plays essential roles in cellular signaling and development, particularly in neuronal and cardiac tissues. CRIM1 functions are crucial for proper cell differentiation and tissue homeostasis, making it an important focus in developmental biology research. Studying CRIM1 can reveal valuable insights into various conditions, including neurodegenerative diseases and cardiac dysfunction. Researchers worldwide rely on CRIM1 monoclonal antibodies to advance their understanding of developmental processes and disease mechanisms. CRIM1 monoclonal antibodies enable detailed examination of protein expression patterns and interactions in various biological systems. CRIM1 monoclonal antibodies from Santa Cruz Biotechnology support researchers in making meaningful contributions to scientific knowledge and potential therapeutic developments.